The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Gut barrier dysfunction in the ApcMin/+ mouse model of colon cancer cachexia
Open accessAbstract
Background The ApcMin/+ mouse, an animal model of colorectal cancer and cachexia, has a heterologous mutation in the Apc tumor suppressor gene, predisposing the mouse to intestinal and colon tumor development. This mouse develops intestinal polyps by ~4 weeks of age, and loses body weight gradually between ~14 and ~20 weeks of age. The strengths of this cachexia model derive from several features that mimic human cancer, including a gradual increase in tumor burden, chronic inflammation, and anemia. Little is known about the role of gut barrier dysfunction and endotoxemia in the development of cancer cachexia. We sought to determine how gut permeability and resultant endotoxemia change with the progression of cachexia. Methods Intestinal gut barrier integrity was assessed by permeability to FITC-dextran (MWav = 4,000 kDa; FD4). Plasma glucose and triglycerides were measured by enzymatic assays, IL-6 by ELISA, and endotoxin by the limulus amoebocyte assay. Body temperature was measured using a rectal probe. Results Progression of cachexia was accompanied by development of gut barrier dysfunction (permeability to FD4), hypertrophy of mesenteric lymph nodes, and an increase in plasma endotoxin concentration. Changes in blood glucose and glucose tolerance, plasma IL-6, triglycerides, and body temperature were characteristic of endotoxemia. Conclusion We propose a role for gut barrier dysfunction (GBD) and subsequent endotoxemia in the development of inflammation and progression of cachexia in the ApcMin/+ mouse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects1
Lambert, G. P. (2009) · Journal of Animal Science · doi:10.2527/jas.2008-1339 · Cited by 529
Increased tight junctional permeability is associated with the development of colon cancer
Soler, A. P. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1425 · Cited by 344
White, J. P., Baynes, J. W., Welle, S. L., Kostek, M. C., Matesic, L. E., Sato, S., & Carson, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024650 · Cited by 260
Self-citationLambert, G. P. (2008) · Medicine and Sport Science · doi:10.1159/000151550 · Cited by 134
Cited by
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
Understanding cachexia as a cancer metabolism syndrome
Porporato, P. E. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.3 · Cited by 562
High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites
Yang, J., Wei, H., Zhou, Y., Szeto, C.-H., Li, C., Lin, Y., Coker, O. O., Lau, H. C. H., Chan, A. W. H., Sung, J. J. Y., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.08.041 · Cited by 536
Reisinger, K. W., van Vugt, J. L. A., Tegels, J. J. W., Snijders, C., Hulsewé, K. W. E., Hoofwijk, A. G. M., Stoot, J. H., Von Meyenfeldt, M. F., Beets, G. L., Derikx, J. P. M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000628 · Cited by 507
Obesity and cancer: inflammation bridges the two
Kolb, R., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 405
Metadata
- Authors
- Puppa, M. J., White, J. P., Sato, S., Cairns, M., Baynes, J. W., & Carson, J. A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 1812
- Issue
- 12
- Pages
- 1601-1606
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2145368264
- Cited by
- 160
- References
- 4
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.